Atricure Inc. buy Needham & Company LLC
Start price
03.11.23
/
50%
€32.40
Target price
03.11.24
€45.71
Performance (%)
-
End price
04.11.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atricure Inc. | 24.460% | 24.460% | -44.194% |
| iShares Core DAX® | 2,59 % | 2,47 % | 8,84 % |
| iShares Nasdaq 100 | -0,91 % | -6,46 % | 24,93 % |
| iShares Nikkei 225® | 0,15 % | -8,77 % | 47,39 % |
| iShares S&P 500 | -0,37 % | -1,22 % | 21,67 % |
Comments by Needham___Company_LL for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at Needham & Company LLC from $68.00 to $49.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat
In the thread Trading Atricure Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten